These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 26059153)

  • 21. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
    Froyen EB; Steinberg FM
    J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
    Breinholt V; Larsen JC
    Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochanin A affects steroidogenesis and estrogen receptor-β expression in porcine granulosa cells.
    Nynca A; Swigonska S; Piasecka J; Kolomycka A; Kaminska B; Radziewicz-Pigiel M; Gut-Nagel M; Ciereszko RE
    Theriogenology; 2013 Oct; 80(7):821-8. PubMed ID: 23953692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4'-acetate on the estrogen signaling pathway in vivo and in vitro.
    Kretzschmar G; Vollmer G; Schwab P; Tischer S; Metz P; Zierau O
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):114-9. PubMed ID: 17631998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
    Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B; Dossing DA; Dimuzio MT
    J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
    Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein.
    Kretzschmar G; Zierau O; Wober J; Tischer S; Metz P; Vollmer G
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):1-6. PubMed ID: 19733663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual effects of daidzein on chicken hepatic vitellogenin II expression and estrogen receptor-mediated transactivation in vitro.
    Ni YD; Hong WJ; Zhou YC; Grossmann R; Zhao RQ
    Steroids; 2010 Mar; 75(3):245-51. PubMed ID: 20043933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
    Lin CC; Tsai YL; Huang MT; Lu YP; Ho CT; Tseng SF; Teng SC
    Carcinogenesis; 2006 Jan; 27(1):131-6. PubMed ID: 16051634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
    Boggess JF; Zhou C; Bae-Jump VL; Gehrig PA; Whang YE
    Gynecol Oncol; 2006 Nov; 103(2):417-24. PubMed ID: 16690106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
    Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
    Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoflavones modulate the glucuronidation of estradiol in human liver microsomes.
    Pfeiffer E; Treiling CR; Hoehle SI; Metzler M
    Carcinogenesis; 2005 Dec; 26(12):2172-8. PubMed ID: 16051636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
    Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
    Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens.
    Boué SM; Wiese TE; Nehls S; Burow ME; Elliott S; Carter-Wientjes CH; Shih BY; McLachlan JA; Cleveland TE
    J Agric Food Chem; 2003 Apr; 51(8):2193-9. PubMed ID: 12670155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogenic in vitro assay on mouse embryonic Leydig cells.
    La Sala G; Farini D; De Felici M
    Int J Dev Biol; 2010; 54(4):717-22. PubMed ID: 20209442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
    King ML; Adler SR; Murphy LL
    Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.
    Simões BM; Kohler B; Clarke RB; Stringer J; Novak-Frazer L; Young K; Rautemaa-Richardson R; Zucchini G; Armstrong A; Howell SJ
    Ther Adv Med Oncol; 2018; 10():1758835918766189. PubMed ID: 29636827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.